Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P0XB | ISIN: FR0013482791 | Ticker-Symbol: 4AW
Tradegate
01.11.24
18:51 Uhr
0,605 Euro
-0,003
-0,49 %
Branche
Unterhaltung
Aktienmarkt
Sonstige
1-Jahres-Chart
NACON SA Chart 1 Jahr
5-Tage-Chart
NACON SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,5860,63213:03
0,6050,61001.11.
GlobeNewswire (Europe)
349 Leser
Artikel bewerten:
(2)

PRESS RELEASE: NACON: STRONG EARNINGS GROWTH IN 2023/24

Press release

Lesquin, 3 June 2024, 6pm CET

STRONG EARNINGS GROWTH IN 2023/24

  • EBITDA: €70.9 MILLION, UP 45%
  • OPERATING INCOME: €20.9 MILLION, UP 20.5%
  • NET INCOME: €17.5 MILLION, UP 37.3%

2024/25: CONTINUING GROWTH IN BUSINESS LEVELS AND OPERATING INCOME

NACON (ISIN FR0013482791) is today announcing consolidated results for its 2023/24 financial year (from 1 April 2023 to 31 March 2024) as finalised by the Board of Directors in its meeting of 3 June 2024.

Consolidated IFRS figures (€ million)2023/24 2022/23Change
Sales (non-IFRS)170.7156.0+9.4%
Adjustment for the partial disposal of Gollum(3.0)
IFRS sales167.7156.0+7.5%
Gross profit
% of sales
104.2
62.1%
92.1
59.1%
+13.1%
Ebitda
% of sales
70.9
42.3%
48.9
31.4%
+45.0%

Operating income
% of sales
20.9
12.5%
17.3
11.1%
+20.5%
Net financial expense

(4.8)

(2.3)
Pre-tax income
% of sales
16.1
9.6%
15.0
9.6%
+7.0%
Income tax1.5(2.2)
Net income for the period
% of sales
17.5
10.5%
12.8
8.2%
+37.3%

Strong earnings growth in 2023/24

During the year, Catalogue sales (new games) were boosted by a heavy release schedule consisting of 19 games, including the highly successful Robocop: Rogue City TM. Catalogue sales amounted to €59.3 million (non-IFRS), up 21.2% relative to 2022/23. The Back Catalogue (games released in previous years) performed very well, with sales rising 7.4% to €44.7 million. The Accessories business generated sales of €62.7 million and returned to growth in the second half of the year, driven by an increase in the installed base of new consoles and new product releases (the RIG 600 PRO headset and the REVOLUTION 5 PRO controller).

Gross margin was 62.1%, an increase of 3 points year-on-year. Ebitda rose by 45% to €70.9 million, giving Ebitda margin of 42.3% as opposed to 31.4% in the previous year.

Operating income rose 20.5% to €20.9 million, equal to 12.5% of sales.

The increase in net financial expense was due to higher interest rates. Exchange differences remained stable (foreign exchange loss of €0.8 million, as in the previous year).

Firm financial position at a time of major development

At 31 March 2024, NACON had equity of €263.6 million as opposed to €242.6 million at 31 March 2023. It also had €26.2 million of cash and cash equivalents versus €47.6 million at 31 March 2023.

Net debt amounted to €85.2 million as opposed to €88.6 million at 30 September 2023. The total amount of NACON's new borrowings during the year was much lower than the amount of borrowings it repaid.

Inventory management efforts and stocking operations reduced inventories by €8.2 million year-on-year to €27.1 million.

With funds from operations rising by 27.3% to €58.0 million during the year and a €17.9 million decrease in the WCR, cash flow from operating activities totalled €73.1 million as opposed to €47.4 million in 2022/23, an increase of 54.4%.

Currently, 45 games are under development, and the related assets have a carrying amount of €129.5 million.

Dividend: in accordance with its policy of using cash flow to fund business development, the Board of Directors decided in its 3 June 2024 meeting not to propose a dividend with respect to the 2023/24 financial year in its upcoming Shareholders' General Meeting.

2024/25: business convergence and continuing growth in sales and operating income

The release schedule will be busy in 2024/25, with around 15 games due to be released during the year including Test Drive Unlimited: Solar CrownTM, scheduled for 12 September 2024, Tour de France 2024, Tiebreak, Ravenswatch (of which almost 500,000 copies have already been sold via early access on PC), Rugby24 and Endurance, along with Greedfall II: The Dying World and Terminator: SurvivorsTM, which will be released via early access.

The Back Catalogue will automatically benefit from the large number of games released in 2023/24, including Robocop: Rogue City TM, which should lead to significant growth.

In Accessories, NACON will continue to reap the rewards of successful product launches in 2023, including the RIG 600 PRO headset and the REVOLUTION 5 PRO controller.
The main development in 2024/25 will be the Group's initiative to bring together its games and accessories activities in the Racing market, along with its new ambitions in this area:

  • Creation of the dedicated NACON Racing department and the "Revosim by Nacon" brand, building on 10 years of expertise in this market;
  • Launches of new premium products (Revosim steering wheel, RIG 900 headset etc.);
  • New licences currently being negotiated.

This will make NACON the only company in the world to offer a comprehensive range of games and accessories for motor racing fans.

In 2024/25, because of the expected momentum in its two business areas, NACON is confident that it will continue to generate growth, accompanied by a further increase in operating income.



ABOUT NACON

2023/2024 IFRS SALES:
€167.7 million





WORKFORCE
More than 1,000 people





INTERNATIONAL PRESENCE
23 subsidiaries and a distribution network in 100 countries
https://corporate.nacongaming.com/ (https://corporate.nacongaming.com/)
NACON is part of the Bigben group and was formed in 2019 to optimise its areas of expertise and generate synergies between them in the video game market. Combining its 16 development studios, AA video game publishing and the design and distribution of premium gaming peripherals, NACON has 30 years of expertise in serving gamers. This new unified business gives NACON a stronger position in its market and enables it to innovate by creating new and unique competitive advantages.



Listed on Euronext Paris, compartment B - Index: CAC Mid&Small
ISIN: FR0013482791; Reuters: NACON.PA; Bloomberg: NACON:FP).



CONTACT:
Cap Value - Gilles Broquelet gbroquelet@capvalue.fr (mailto:gbroquelet@capvalue.fr) - +33 1 80 81 50 01

GLOSSARY

Back Catalogue: games released in previous years

Gross profit: sales minus purchases used in the business.
Ebitda: earnings before interest, tax, depreciation of property, plant and equipment and amortisation of intangible assets

Attachment

  • CP_Nacon_RA 2023_24 English Diffusion (https://ml.globenewswire.com/Resource/Download/e6d45f81-5041-4902-9722-5e3a2d550779)

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.